In accordance with this clinical observation is the experimental finding that deletion of another member of the TGF family, TGF-β has been shown to improve bacterial clearance and diminished intracranial complication in a mouse with pneumococcal meningitis [40]. This evidence concerns the gene TGFB1 and pneumococcal meningitis.